Evidence map›Paper›PMID 27389192›Full record

ArticlePloS one2016

Activation of the IL-2 Receptor in Podocytes: A Potential Mechanism for Podocyte Injury in Idiopathic Nephrotic Syndrome?

Arnold H Zea, Tyrus Stewart, Jeannine Ascani, David J Tate, Beatriz Finkel-Jimenez, Anna Wilk, Krzysztof Reiss, William E Smoyer, Diego H Aviles

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Old and New Calcineurin Inhibitors in Lupus Nephritis.Journal of clinical medicine · 2021
    Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 1 country.

Arnold H ZeaDepartment of Microbiology, Immunology, and Parasitology, Louisiana State University Health Sciences Center, New Orleans, Louisiana, United States of America.
Tyrus StewartDepartment of Pediatric Nephrology, Louisiana State University Health Sciences Center, New Orleans, Louisiana, United States of America.
Jeannine AscaniDepartment of Research Ochsner Biobank, Ochsner Health System, New Orleans, Louisiana, United States of America.
David J TateEurofins Central Analytical Laboratories, New Orleans, Louisiana, United States of America.
Beatriz Finkel-JimenezDepartment of Medical Microbiology and Immunology, American University of the Caribbean School of Medicine, Coral Gables, Florida, United States of America.
Anna WilkDepartment of Genetics, Louisiana State University Health Sciences Center, New Orleans, Louisiana, United States of America.
Krzysztof ReissDepartment of Genetics, Louisiana State University Health Sciences Center, New Orleans, Louisiana, United States of America.
William E SmoyerDepartment of Nephrology, Nationwide Children's Hospital, Columbus, Ohio, United States of America.
Diego H AvilesDepartment of Pediatric Nephrology, Louisiana State University Health Sciences Center, New Orleans, Louisiana, United States of America.
Louisiana State University Health Sciences Center New Orleans · USAmerican University · USEurofins (United States) · USNationwide Children's Hospital · USOchsner Health System · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The renal podocyte plays an important role in maintaining the structural integrity of the glomerular basement membrane. We have previously reported that patients with idiopathic nephrotic syndrome (INS) have increased IL-2 production. We hypothesized that podocytes express an IL-2 receptor (IL-2R) and signaling through this receptor can result in podocyte injury. To confirm the presence of the IL-2R, we tested a conditionally immortalized murine podocyte cell line by flow cytometry, qPCR, and Western blot. To test for the presence of the IL-2R in vivo, immunohistochemical staining was performed on human renal biopsies in children with FSGS and control. Podocytes were stimulated with IL-2 in vitro, to study signaling events via the JAK/STAT pathway. The results showed that stimulation with IL-2 resulted in increased mRNA and protein expression of STAT 5a, phosphorylated STAT 5, JAK 3, and phosphorylated JAK 3. We then investigated for signs of cellular injury and the data showed that pro-apoptotic markers Bax and cFLIP were significantly increased following IL-2 exposure, whereas LC3 II was decreased. Furthermore, mitochondrial depolarization and apoptosis were both significantly increased following activation of the IL-2R. We used a paracellular permeability assay to monitor the structural integrity of a podocyte monolayer following IL-2 exposure. The results showed that podocytes exposed to IL-2 have increased albumin leakage across the monolayer. We conclude that murine podocytes express the IL-2R, and that activation through the IL-2R results in podocyte injury.

Indexed as

AlbuminsAnimalsApoptosisBiopsyChildDisease Models, AnimalHumansImmunosuppressive AgentsMembrane Potential, MitochondrialMiceMitochondriaNephrotic SyndromePhosphorylationPodocytesPolymerase Chain ReactionReceptors, Interleukin-2AlbuminsImmunosuppressive AgentsReceptors, Interleukin-2

Identifiers

PMID27389192
PMCPMC4936730
OpenAlexW2464059619

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.